(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

JOLIMAY BIOMOLECULAR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

JOLIMAY BIOMOLECULAR

ST13

US500000097734514

Class

3

Filing

97734514

Registration

7382422

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

05/07/2024

Trademark type

Combined

Nice classes

3

Filing date

12/28/2022

Registration date

05/07/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/07/2024

Last transaction

05/07/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/30/2021

First use in commerce

06/30/2021

Drawing code

3

Owner type

16

Owner location

Morton, IL

Examiner

TOOLEY, DAVID

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Jolimay Biomolecular LLC

Representatives

Robert Wright WRIGHT LAW OFFICE, PLLC

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Non-medicated facial and eye serum containing antioxidants; Facial cream; Skin and body topical lotionscreams and oils for cosmetic use

Publications

History of USPTO decisions and trademark events.

21 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/07/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/07/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/02/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/01/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/23/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/23/2024

IUAF

USE AMENDMENT FILED

01/31/2024

EISU

TEAS STATEMENT OF USE RECEIVED

01/31/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/26/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/31/2023

PUBO

PUBLISHED FOR OPPOSITION

10/31/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/11/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/27/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

09/27/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/27/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

09/27/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/27/2023

DOCK

ASSIGNED TO EXAMINER

09/25/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/24/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/23/2023

NWAP

NEW APPLICATION ENTERED

12/31/2022

Continuous trademark protection

Get notified about every new filing that threatens JOLIMAY BIOMOLECULAR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.